BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of investors of Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) concerning the Company and its officers’ possible violations of federal securities laws.
Neovasc is a specialty medical device company that develops, manufactures, and markets cardiovascular products worldwide.
On May 19, 2016, a Massachusetts federal jury awarded a $70 million verdict to Neovasc’s rival, CardiAQ Valve Technologies Inc. (“CardiAQ”), after finding that Neovasc had stolen trade secrets from CardiAQ.
On this news, Neovasc's shares fallen by $1.38 per share, or 75%, to close on May 20, 2016 at $0.46 per share.
If you purchased Neovasc securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.